Athletes who suffer repeated head injuries are at significantly higher risk of developing neurodegenerative diseases later in life than the general population, with a reported 3-fold risk of death from Alzheimer’s disease or ALS. Yet according to the Center for Disease Control, no treatment for concussion or traumatic brain injury (TBI) has proven to be effective. A new $17M award from the Department of Defense (DoD) to a multidisciplinary team led by Geoffrey Manley, Chief of Neurosurgery at the San Francisco General Hospital and Trauma Center, aims to improve TBI clinical trial success. The new initiative, called the TBI Endpoints Development (TED) Award, combines leaders from universities, industry, and patient advocacy organizations in an effort to create comprehensive databases that can serve as a key resource for developing better tools and standards for TBI clinical trials.
Click here to read more about this exciting initiative.Share this: